The iCMLf is sharing a series of valuable expert opinions and webinars from other resources that address questions on how to best manage patients with COVID-19 and CML.

Professor Jeff Lipton Princess Margaret Hospital Toronto, Canada
|
|
Expert Opinion: Interferon and CML during the COVID-19 Pandemic
Read the full expert opinion here
|
- Prof Claire Harrison, UK
- Dr Felicetto Ferrara, Italy
- Dr Delphine Réa, France
|
|
EHA/EHA-SWG Webinar: COVID-19 and myeloid malignancies: Managing patients during the pandemic
Watch the webinar to hear the experts' perspectives on topics like;
- COVID-19 Centre and MPN disease specific experience
- COVID-19 and Acute Myeloid Leukemia
- COVID-19 and Chronic Myeloid Leukeumia
- Q&A Session
Click here to see the EHA/EHA-SWG webinar Source: www.ehaweb.org/covid-19/
|

- Prof Alessandro Rambaldi, Italy
- Prof Jose M. Ribera, Spain
- Prof Marie von Lilienfeld-Toal, Germany
- Prof Malgorzata Mikulska, Italy
|
|
EHA/EBMT Webinar: Experts take key questions for the mangement of patients with hematological diseases during coronavirus
Watch the webinar to hear the experts' perspectives on questions like;
- What are your views on the treatment of COVID-19 patients with hematological diseases?
- Would you recommend specific means to prevent COVID-19 for patients with hematological diseases?
- Did you see any increase in the incidence of COVID-19 infections in patients who underwent intensive chemotherapy or transplantation?
- Do you recommend postponing curative chemotherapy or transplantation for COVID-19 patients with hematological diseases?
- Which treatment options are there for patients with hematological diseases? Anti-viral and anti-inflammatory agents?
Click here to see the EHA/EBMT webinar Source: www.ehaweb.org/covid-19/
|

Prof. Michael Mauro Memorial Sloan Kettering Cancer Center New York, USA
|
|
PatientPower Interview: Expert takes questions from patients and care partners on managing chronic myeloid leukemia during coronavirus
Watch the expert video to hear Dr. Mauro's perspective on questions like,
- Are CML patients at higher risk for COVID-19?
- How does treatment impact immunity?
- When a vaccine is available, will CML patients be able to take it?
- Are there any concerns about medicine supply?
Click here to see the PatientPower expert video Source: www.patientpower.info
|